BeOne Medicines (BEIGF) EBITDA Margin (2015 - 2026)
BeOne Medicines (BEIGF) reported EBITDA Margin of 16.51% for Q1 2026, up 1552.0% year-over-year from 1.0% in Q1 2025, and up 33.69% quarter-over-quarter from 12.35% in Q4 2025.
BeOne Medicines (BEIGF) EBITDA Margin (2015 - 2026) Analysis & Trends
BeOne Medicines (BEIGF) has 12 years of EBITDA Margin data on file, last reported at 16.51% in Q1 2026.
- EBITDA Margin for Q1 2026 came in at 16.51%, up 1552.0% year-over-year; the trailing twelve-month figure through Mar 2026 was 11.95% (up 1903.0% YoY), and the FY2025 annual result was 8.37%, up 2328.0% from the prior year.
- EBITDA Margin grew to 16.51% in Q1 2026 per BEIGF's latest filing, from 12.35% in the prior quarter.
- Over five years, EBITDA Margin peaked at 16.51% in Q1 2026 and troughed at 144.57% in Q1 2022.
- A 5-year average of 43.58% and a median of 17.15% in 2023 frame the typical range for EBITDA Margin.
- On a YoY basis, EBITDA Margin climbed as much as 18794 bps in 2022 and fell as far as 21235 bps in 2022.
- A 5-year view of EBITDA Margin shows it stood at 123.29% in 2022, then jumped by 51 bps to 60.5% in 2023, then jumped by 88 bps to 7.04% in 2024, then jumped by 275 bps to 12.35% in 2025, then surged by 34 bps to 16.51% in 2026.
- Business Quant data shows BEIGF's EBITDA Margin at 16.51% in Q1 2026, 12.35% in Q4 2025, and 11.55% in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 821,726.73 Bn | 821,726.69 Bn | - | - |
| 2 | Belite Bio | 57,768.00 Bn | 57,768.00 Bn | - | - |
| 3 | Quantum Biopharma | 16,655.88 Bn | 16,655.88 Bn | - | - |
| 4 | Legend Biotech | 3,540.00 Bn | 3,539.71 Bn | 242.10 Mn | -6.43% |
| 5 | Evaxion A | 1,526.26 Bn | 1,526.24 Bn | - | - |
| 6 | Akari Therapeutics | 1,520.09 Bn | 1,520.09 Bn | - | - |
| 7 | Psyence Biomedical | 223.87 Bn | 223.87 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.47 Bn | 107.23 Bn | 2.59 Bn | 38.10% |
| 9 | Abivax | 91.22 Bn | 91.22 Bn | - | - |
| 10 | BeOne Medicines | - | - | 1.35 Bn | 16.51% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 16.51% |
| Dec 31, 2025 | 12.35% |
| Sep 30, 2025 | 11.55% |
| Jun 30, 2025 | 6.68% |
| Mar 31, 2025 | 0.99% |
| Dec 31, 2024 | -7.04% |
| Sep 30, 2024 | -12.01% |
| Jun 30, 2024 | -11.53% |
| Mar 31, 2024 | -34.77% |
| Dec 31, 2023 | -60.50% |
| Sep 30, 2023 | -17.15% |
| Jun 30, 2023 | -53.54% |
| Mar 31, 2023 | -82.91% |
| Dec 31, 2022 | -123.29% |
| Sep 30, 2022 | -113.09% |
| Jun 30, 2022 | -128.64% |
| Mar 31, 2022 | -144.57% |
| Dec 31, 2021 | 89.06% |
| Sep 30, 2021 | -223.95% |
| Jun 30, 2021 | -316.58% |